Skip to main content
Top
Published in: World Journal of Surgery 8/2013

01-08-2013

Influence of Prophylactic Neck Dissection on Rate of Retreatment for Papillary Thyroid Carcinoma

Authors: Dana M. Hartl, Elisabeth Mamelle, Isabelle Borget, Sophie Leboulleux, Haïtham Mirghani, Martin Schlumberger

Published in: World Journal of Surgery | Issue 8/2013

Login to get access

Abstract

Background

Prophylactic neck dissection (PND) for papillary thyroid cancer is controversial. The objective of this study was to analyze the influence of PND on the rate of retreatment.

Methods

In this retrospective case-control study, papillary thyroid carcinomas >10 mm without ultrasonographic evidence of nodal disease (cN0) were treated with total thyroidectomy (TT) or TT with bilateral central compartment PND. All received postoperative radioactive iodine (131I) and were followed for at least 1 year. We compared the rate of retreatment (surgery or 131I).

Results

Altogether, 246 patients (mean age 46 years, 78 % women) underwent TT (n = 91) or TT + PND (n = 155). The groups were similar in age, sex, tumor size, and follow-up (median 6.3 years) (p > 0.05). Overall, 11 (12 %) of the patients in the TT group underwent reoperation in the central compartment for recurrence versus 3 (2 %) in the TT + PND group (p < 0.001). There were 1.18 administrations of 131I for the TT group versus 1.08 for the TT + PND group (p = 0.08). The average cumulative dose of 131I was 3.9 ± 1.8 GBq for the TT group and 3.8 ± 1.3 GBq for the TT + PND group (p = 0.52). Actuarial (Kaplan-Meier) 5-year retreatment rates were 14.7 % in the TT group and 6.5 % in the TT + PND group (p = 0.01, log-rank). The rate of permanent recurrent nerve paralysis was 2 % for the TT group and 1 % for the TT + PND group (p = 0.98). The rates of permanent hypoparathyroidism were 7 versus 3 %, respectively (p = 0.12).

Conclusions

Five-year retreatment rates were lower in patients treated with PND, with no added permanent morbidity.
Literature
2.
go back to reference Pisanu A, Deplano D, Pili M et al (2011) Larger tumor size predicts nodal involvement in patients with follicular thyroid carcinoma. Tumori 97:296–303PubMed Pisanu A, Deplano D, Pili M et al (2011) Larger tumor size predicts nodal involvement in patients with follicular thyroid carcinoma. Tumori 97:296–303PubMed
3.
go back to reference Robbins KT, Clayman G, Levine PA et al (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751–758PubMedCrossRef Robbins KT, Clayman G, Levine PA et al (2002) Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128:751–758PubMedCrossRef
4.
go back to reference Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158PubMedCrossRef Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158PubMedCrossRef
5.
go back to reference Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef
6.
go back to reference Bardet S, Malville E, Rame JP et al (2008) Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 158:551–560PubMedCrossRef Bardet S, Malville E, Rame JP et al (2008) Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 158:551–560PubMedCrossRef
7.
go back to reference Podnos YD, Smith D, Wagman LD et al (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731–734PubMed Podnos YD, Smith D, Wagman LD et al (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731–734PubMed
8.
go back to reference Zaydfudim V, Feurer ID, Griffin et al (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070–1077 discussion 1077–1078PubMedCrossRef Zaydfudim V, Feurer ID, Griffin et al (2008) The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070–1077 discussion 1077–1078PubMedCrossRef
9.
go back to reference Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–381 discussion 381–374PubMedCrossRef Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–381 discussion 381–374PubMedCrossRef
10.
go back to reference Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689PubMedCrossRef Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689PubMedCrossRef
11.
go back to reference Zetoune T, Keutgen X, Buitrago D et al (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17:3287–3293PubMedCrossRef Zetoune T, Keutgen X, Buitrago D et al (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17:3287–3293PubMedCrossRef
12.
go back to reference Shaha AR (1998) Thyroid carcinoma: implications of prognostic factors. Cancer 83:401–402 discussion 403–404PubMedCrossRef Shaha AR (1998) Thyroid carcinoma: implications of prognostic factors. Cancer 83:401–402 discussion 403–404PubMedCrossRef
13.
go back to reference Popadich A, Levin O, Lee JC et al (2011) A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 150:1048–1057PubMedCrossRef Popadich A, Levin O, Lee JC et al (2011) A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 150:1048–1057PubMedCrossRef
14.
go back to reference Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope 119:1135–1139PubMedCrossRef Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope 119:1135–1139PubMedCrossRef
15.
go back to reference Alvarado R, Sywak MS, Delbridge L et al (2009) Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Surgery 145:514–518PubMedCrossRef Alvarado R, Sywak MS, Delbridge L et al (2009) Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Surgery 145:514–518PubMedCrossRef
16.
go back to reference Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg 145:272–275PubMedCrossRef Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg 145:272–275PubMedCrossRef
17.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind CW (2010) TNM classification of malignant tumors. Wiley-Blackwell, West Sussex, pp 58–61 Sobin LH, Gospodarowicz MK, Wittekind CW (2010) TNM classification of malignant tumors. Wiley-Blackwell, West Sussex, pp 58–61
18.
go back to reference Bonnet S, Hartl D, Leboulleux S et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167PubMedCrossRef Bonnet S, Hartl D, Leboulleux S et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167PubMedCrossRef
19.
go back to reference Hughes DT, White ML, Miller BS et al (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148:1100–1107PubMedCrossRef Hughes DT, White ML, Miller BS et al (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148:1100–1107PubMedCrossRef
20.
go back to reference Hartl DM, Leboulleux S, Al Ghuzlan A et al (2012) Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 255:777–783PubMedCrossRef Hartl DM, Leboulleux S, Al Ghuzlan A et al (2012) Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 255:777–783PubMedCrossRef
21.
go back to reference Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536–538PubMedCrossRef Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134:536–538PubMedCrossRef
22.
go back to reference Hughes DT, Doherty GM (2011) Central neck dissection for papillary thyroid cancer. Cancer Control 18:83–88PubMed Hughes DT, Doherty GM (2011) Central neck dissection for papillary thyroid cancer. Cancer Control 18:83–88PubMed
23.
25.
go back to reference Schlumberger M, Catargi B, Borget I et al (2012) Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med 366:1663–1673PubMedCrossRef Schlumberger M, Catargi B, Borget I et al (2012) Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med 366:1663–1673PubMedCrossRef
26.
go back to reference Mallick U, Harmer C, Yap B et al (2012) Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl J Med 366:1674–1685PubMedCrossRef Mallick U, Harmer C, Yap B et al (2012) Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl J Med 366:1674–1685PubMedCrossRef
27.
go back to reference Brassard M, Borget I, Edet-Sanson A et al (2011) Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab 96:1352–1359PubMedCrossRef Brassard M, Borget I, Edet-Sanson A et al (2011) Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab 96:1352–1359PubMedCrossRef
28.
go back to reference Tuttle RM, Rondeau G, Lee NY (2011) A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer. Cancer Control 18:89–95PubMed Tuttle RM, Rondeau G, Lee NY (2011) A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer. Cancer Control 18:89–95PubMed
29.
go back to reference Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1005 discussion 1005–1007PubMedCrossRef Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1005 discussion 1005–1007PubMedCrossRef
30.
go back to reference So YK, Seo MY, Son YI (2012) Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications. Surgery 151:192–198PubMedCrossRef So YK, Seo MY, Son YI (2012) Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications. Surgery 151:192–198PubMedCrossRef
31.
go back to reference Lang BH, Wong KP, Wan KY et al (2012) Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol 19:60–67PubMedCrossRef Lang BH, Wong KP, Wan KY et al (2012) Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol 19:60–67PubMedCrossRef
32.
go back to reference McHenry CR (2011) Prophylactic central compartment neck dissection for papillary thyroid cancer: the search for justification continues. Surgery 150:1058–1060PubMedCrossRef McHenry CR (2011) Prophylactic central compartment neck dissection for papillary thyroid cancer: the search for justification continues. Surgery 150:1058–1060PubMedCrossRef
33.
go back to reference Balasubramanian SP, Harrison BJ (2011) Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg 98:334–344PubMedCrossRef Balasubramanian SP, Harrison BJ (2011) Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg 98:334–344PubMedCrossRef
34.
go back to reference Ito Y, Tsushima Y, Masuoka H et al (2011) Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1–3.0 cm: first report of a trial at Kuma Hospital. Surg Today 41:1486–1491PubMedCrossRef Ito Y, Tsushima Y, Masuoka H et al (2011) Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1–3.0 cm: first report of a trial at Kuma Hospital. Surg Today 41:1486–1491PubMedCrossRef
35.
go back to reference Machens A, Holzhausen HJ, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139:43–45PubMedCrossRef Machens A, Holzhausen HJ, Dralle H (2004) Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 139:43–45PubMedCrossRef
36.
go back to reference Yang WT, Goldberg BB (2011) Microbubble contrast-enhanced ultrasound for sentinel lymph node detection: Ready for prime time? AJR Am J Roentgenol 196:249–250PubMedCrossRef Yang WT, Goldberg BB (2011) Microbubble contrast-enhanced ultrasound for sentinel lymph node detection: Ready for prime time? AJR Am J Roentgenol 196:249–250PubMedCrossRef
37.
go back to reference De Giorgi V, Gori A, Grazzini M et al (2010) Contrast-enhanced ultrasound: a filter role in AJCC stage I/II melanoma patients. Oncology 79:370–375PubMedCrossRef De Giorgi V, Gori A, Grazzini M et al (2010) Contrast-enhanced ultrasound: a filter role in AJCC stage I/II melanoma patients. Oncology 79:370–375PubMedCrossRef
38.
go back to reference Curry JM, Ezzat WH, Merton DA et al (2009) Thyroid lymphosonography: a novel method for evaluating lymphatic drainage. Ann Otol Rhinol Laryngol 118:645–650PubMed Curry JM, Ezzat WH, Merton DA et al (2009) Thyroid lymphosonography: a novel method for evaluating lymphatic drainage. Ann Otol Rhinol Laryngol 118:645–650PubMed
Metadata
Title
Influence of Prophylactic Neck Dissection on Rate of Retreatment for Papillary Thyroid Carcinoma
Authors
Dana M. Hartl
Elisabeth Mamelle
Isabelle Borget
Sophie Leboulleux
Haïtham Mirghani
Martin Schlumberger
Publication date
01-08-2013
Publisher
Springer US
Published in
World Journal of Surgery / Issue 8/2013
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2089-3

Other articles of this Issue 8/2013

World Journal of Surgery 8/2013 Go to the issue